Clinical and biological significance of a − 73A > C variation in the CDH1 promoter of patients with sporadic gastric carcinoma
- 22 November 2017
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 21 (4) , 606-616
Abstract
CDH1 germline mutations lead to hereditary diffuse gastric carcinomas. However, it is unclear whether genetic variations in the CDH1 promoter affect the progression of sporadic gastric carcinomas (SGCs).Keywords
Funding Information
- National Natural Science Foundation of China (81572762, 31261140372, 31261140372)
- National Basic Research Program of China (2015CB553902)
This publication has 34 references indexed in Scilit:
- Landscape of X chromosome inactivation across human tissuesNature, 2017
- Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric CancerJournal of Clinical Oncology, 2013
- Promoter Polymorphisms and Methylation of E-Cadherin (CDH1) and KIT in Gastric Cancer Patients from Northern Brazil2010
- Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patientsMolecular Cancer, 2009
- Hypermethylation of E‐cadherin is an independent predictor of improved survival in head and neck squamous cell carcinomaCancer, 2008
- [Analysis of demethylation-related HPV16 reactivation by DHPLC-primer extension assay].2007
- Combined Bisulfite Restriction Analysis (COBRA)2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancerNature Genetics, 2000
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996